A prospective, randomized, open-label, comparative trial of dideoxyinosine (ddI) versus dideoxycytidine (ddC) in HIV-infected patients who are intolerant of or who have failed zidovudine (AZT) therapy

Trial Profile

A prospective, randomized, open-label, comparative trial of dideoxyinosine (ddI) versus dideoxycytidine (ddC) in HIV-infected patients who are intolerant of or who have failed zidovudine (AZT) therapy

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 12 Oct 2005

At a glance

  • Drugs Didanosine; Zalcitabine
  • Indications HIV infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 12 Oct 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top